Symbicort

Designed to manage asthma and chronic obstructive pulmonary disease, intended to alleviate airway inflammation and support breathing function in patients.

Strengths: 160/4.5mcg

Medicine details

Alternative names

Budesonide Formoterol Inhaler; Budesonide Formoterol Rotacaps Inhaler

Therapeutic class

Inhaled Corticosteroid / Long-acting Beta2 Agonist

Pharmacological class

Corticosteroid; Beta2-adrenergic Agonist

Contraindications

hypersensitivity to active substances

Minor side effects

headache; palpitations

Moderate side effects

oral candidiasis; throat irritation

Dosage forms

Inhalation powder

Administration route

Inhalation use

Prescription status

POM

Manufacturer

AstraZeneca

Onset Time

1–3 minutes

Duration

12 hours

Storage instructions

Store at room temperature below 30°C.

Drug interactions

beta blockers; ketoconazole

Age restrictions

Children and adults, as prescribed.

Precautions and warnings

rinse mouth after use to prevent fungal infection; monitor for increased heart rate

Serious side effects

bronchospasm — requires immediate medical attention; pneumonia — requires immediate medical attention

Patient summary

Designed to manage asthma and chronic obstructive pulmonary disease, intended to alleviate airway inflammation and support breathing function in patients.

Mechanism of action

This medication combines an inhaled corticosteroid, which reduces inflammation and swelling in the airways, and a long-acting beta2 agonist, which relaxes the bronchial muscles. Together, they provide both preventive control and rapid relief by maintaining open airways and reducing allergic responses.

Pregnancy and breastfeeding

Pregnancy: use only if clearly indicated after medical assessment. Breastfeeding: use with caution as these components pass into breast milk.

Symbicort

Designed to manage asthma and chronic obstructive pulmonary disease, intended to alleviate airway inflammation and support breathing function in patients.

Editorial Notes

  • Active ingredient(s): Budesonide, Formoterol
  • Listed indication(s): Asthma, Chronic Obstructive Pulmonary Disease

Available option

  • 3 inhalers - 160/4.5 mcg982-160-4-5-mcg-12197